Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Boehm-Viswanathan

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Current Opinion in Oncology|February 25, 2000
Is angiogenesis inhibition the Holy Grail of cancer therapy?T Boehm-Viswanathan
International Journal of Molecular Medicine|September 24, 1999
Why angiogenesis inhibition? CommentaryT Boehm-Viswanathan
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|February 25, 2000
Is angiogenesis inhibition the Holy Grail of cancer therapy?T Boehm-Viswanathan
International Journal of Molecular Medicine|September 24, 1999
Why angiogenesis inhibition? CommentaryT Boehm-Viswanathan
Pageof 1